| Symbol | CSTL |
|---|---|
| Name | CASTLE BIOSCIENCES INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Services-Medical Laboratories |
| Address | 1500 W. PARKWOOD AVE., FRIENDSWOOD, TX 77546 |
| Telephone | 866-788-9007 |
| Fax | — |
| — | |
| Website | https://www.castlebiosciences.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001447362 |
| Description | Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Additional info from NASDAQ: |
📋 Tobin Juvenal (Chief Commercial Officer) plans to sell 22K shares of Castle Biosciences, Inc. (at $28.00 each, total $630K) Filed: Jul 31, 2026 | ID: 000471
Read more📋 Derek Maetzold (Officer) plans to sell 68K shares of Castle Biosciences, Inc. (at $28.00 each, total $1.9M) Filed: Jul 31, 2026 | ID: 000470
Read more(30% Negative) CASTLE BIOSCIENCES INC (CSTL) Reports Q3 2026 Financial Results
Read moreDirector MAETZOLD DEREK J 🟡 adjusted position in 9.8K shares (1 derivative) of CASTLE BIOSCIENCES INC (CSTL) at $25.06 Transaction Date: Jul 27, 2026 | Filing ID: 050616
Read moreCastle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference
Read moreDirector MAETZOLD DEREK J 🟡 adjusted position in 4.2K shares (1 derivative) of CASTLE BIOSCIENCES INC (CSTL) at $22.92 Transaction Date: Jul 14, 2026 | Filing ID: 048461
Read moreDirector MAETZOLD DEREK J 🟡 adjusted position in 9.8K shares (1 derivative) of CASTLE BIOSCIENCES INC (CSTL) at $24.29 Transaction Date: Jul 01, 2026 | Filing ID: 047287
Read moreOelschlager Kristen M 🔴 sold 8.6K shares of CASTLE BIOSCIENCES INC (CSTL) at $24.78 Transaction Date: Jul 01, 2026 | Filing ID: 047286
Read moreCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreDirector MAETZOLD DEREK J 🟡 adjusted position in 4.2K shares (1 derivative) of CASTLE BIOSCIENCES INC (CSTL) at $20.66 Transaction Date: Jun 15, 2026 | Filing ID: 044019
Read more